Veracyte (VCYT) Misses Q3 EPS by 2c

Veracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9.67 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in